{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"tb-500-carpal-tunnel","title":"TB-500 for Carpal Tunnel Syndrome: What the Evidence Shows","body":"## What's breaking down if you have Carpal tunnel syndrome\n\nCarpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel in the wrist. The flexor retinaculum ligament thickens or swells, pressure builds on the nerve and surrounding tendons. This leads to inflammation that does not clear quickly, restricted blood flow, and disrupted nerve signaling. Over time, the protective myelin around the nerve can degrade, and tendon gliding becomes impaired. Repair cells often fail to reach the compressed area efficiently because of poor migration through inflamed or scarred tissue. Actin and cytoskeleton organization in cells around the site can become disorganized, slowing structural rebuilding.\n\nThe core issue is a mismatch: breakdown and compression outpace the body's ability to clear inflammation and send repair cells where they are needed most.\n\n## Why TB-500 might help you\n\n1. You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\nIf your carpal tunnel involves persistent swelling around the nerve and tendons plus slow tissue remodeling, the pathways linked to TB-500 address cell movement and actin regulation that preclinical work associates with better repair-cell delivery to injury sites.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **TB-500** → inflammation clearance / repair-cell migration\n\n## What the evidence actually shows\n\nNo completed human interventional trials exist that test TB-500 specifically for carpal tunnel syndrome (scoping review of 80 studies, 2026). Human data on thymosin beta-4 (the parent peptide) is limited to safety studies in healthy volunteers and small trials in ocular or cardiac settings. Preclinical work in animals shows thymosin beta-4 promotes cell migration, angiogenesis, and reduced inflammation in wound and tendon models. One scoping review mapped evidence as heavily weighted toward in vitro and animal designs, with sparse direct musculoskeletal human data.\n\n## What scientists say\n\nResearchers note that thymosin beta-4 supports actin sequestration and cell motility in repair contexts, but emphasize the absence of randomized controlled trials in nerve compression or tendon sheath conditions like carpal tunnel. A 2026 review concluded the literature supports interest in repair pathways yet remains largely preclinical for musculoskeletal applications.\n\n## What people say on Reddit\n\nAnecdotal reports appear in r/carpaltunnel and r/Peptides. Users describe combining TB-500 with BPC-157 and reporting reduced numbness, less pain with repetitive use, and improved thumb pad comfort within weeks. One user stated relief was \"almost immediate\" after injection near the pain site. Another noted help with tendon issues in hands and arms after a fall. Several threads mention post-surgery use or attempts to avoid surgery. These remain individual experiences without controlled verification.\n\n## What people say on X\n\nPublic posts on X echo similar themes of users trying TB-500 blends for wrist and nerve issues, often alongside other peptides, with reports of faster perceived recovery from repetitive strain. No large verified cohort data appears.\n\n## What we do not know\n\nNo human efficacy trials measure nerve conduction, symptom scores, or imaging changes after TB-500 in carpal tunnel patients. Long-term outcomes, optimal timing relative to compression severity, and whether effects differ from placebo are unknown. Direct comparisons to standard care such as splinting or corticosteroid injection do not exist.\n\n## Safety and limits\n\nPhase 1 safety data on recombinant thymosin beta-4 in healthy volunteers reported good tolerability at tested doses with no serious adverse events noted. Broader human safety data for the TB-500 fragment in carpal tunnel contexts is absent. Regulatory status limits approved medical use; any application remains experimental. Individual responses vary and monitoring by a qualified clinician is essential.\n\n(Word count approximately 1250)","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/tb-500-carpal-tunnel/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No completed human interventional trials test TB-500 for carpal tunnel syndrome.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the evidence gap for this specific condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"A 2026 scoping review found evidence for thymosin beta-4 and TB-500 heavily preclinical with limited human musculoskeletal data.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s1"],"source_status":"sourced","why_material":"Grades the overall literature base.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Reddit users report subjective pain and numbness reduction with TB-500 plus BPC-157 in carpal tunnel threads.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Documents real-world user reports separately from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Thymosin beta-4 pathways are studied for promoting cell migration and actin regulation in tissue repair.","section":"Why TB-500 might help you","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Links the peptide's researched actions to the condition's repair layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://www.mdpi.com/2076-3417/16/12/6202","title":"Thymosin Beta-4 and TB-500 in Tissue Healing: A Scoping Review","quote":"The evidence base was weighted toward mixed and in vitro designs... Human evidence directly relevant to musculoskeletal applications was limited, and direct TB-500 evidence was minimal.","summary":"2026 scoping review mapping TB-500/Tβ4 evidence; no human interventional musculoskeletal trials identified for administered peptide.","claim_ids":["c1","c2","c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:41:59.529Z","link_status":"http_403","quote_status":"unverified","prev":"genesis","hash":"03fe79c420da85b83c16a0aa6188d80b8d03b59f13257d64c6812c7b0617772c"},{"id":"s2","type":"reddit","url":"https://www.reddit.com/r/carpaltunnel/comments/1j2tdik/has_anyone_tried_peptide_treatment_to_help_with/","title":"Has anyone tried peptide treatment to help with Carpal tunnel pain?","quote":"bpc157/ tb500 relieved the pain almost immediately.","summary":"User report of rapid subjective relief from BPC-157/TB-500 blend in carpal tunnel.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:41:59.529Z","link_status":"ok","quote_status":"unverified","prev":"03fe79c420da85b83c16a0aa6188d80b8d03b59f13257d64c6812c7b0617772c","hash":"86deb4d5e858ce4268c8ff98c9567ba00c0a0342ad8edfc0f732ad4ce575bf3f"},{"id":"s3","type":"reddit","url":"https://www.reddit.com/r/carpaltunnel/comments/1qsstn0/peptides/","title":"Peptides?","quote":"My mom used it and claimed it helped completely gone. Specifically bpc-157 and tb-500. I'm currently taking it for my thenar thumb pad pain and it has helped.","summary":"Additional anecdotal reports of symptom improvement with the blend.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:41:59.529Z","link_status":"ok","quote_status":"unverified","prev":"86deb4d5e858ce4268c8ff98c9567ba00c0a0342ad8edfc0f732ad4ce575bf3f","hash":"f3a039771d5f33568e7b0b40e2973c794fa6e6ab2a73ac66ceff166526d1e8fd"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:41:59.973Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"TB-500 for Carpal Tunnel Syndrome: What the Evidence Shows","register":"source_ledger","body":"## What's breaking down if you have Carpal tunnel syndrome\n\nCarpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel in the wrist. The flexor retinaculum ligament thickens or swells, pressure builds on the nerve and surrounding tendons. This leads to inflammation that does not clear quickly, restricted blood flow, and disrupted nerve signaling. Over time, the protective myelin around the nerve can degrade, and tendon gliding becomes impaired. Repair cells often fail to reach the compressed area efficiently because of poor migration through inflamed or scarred tissue. Actin and cytoskeleton organization in cells around the site can become disorganized, slowing structural rebuilding.\n\nThe core issue is a mismatch: breakdown and compression outpace the body's ability to clear inflammation and send repair cells where they are needed most.\n\n## Why TB-500 might help you\n\n1. You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\nIf your carpal tunnel involves persistent swelling around the nerve and tendons plus slow tissue remodeling, the pathways linked to TB-500 address cell movement and actin regulation that preclinical work associates with better repair-cell delivery to injury sites.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **TB-500** → inflammation clearance / repair-cell migration\n\n## What the evidence actually shows\n\nNo completed human interventional trials exist that test TB-500 specifically for carpal tunnel syndrome (scoping review of 80 studies, 2026). Human data on thymosin beta-4 (the parent peptide) is limited to safety studies in healthy volunteers and small trials in ocular or cardiac settings. Preclinical work in animals shows thymosin beta-4 promotes cell migration, angiogenesis, and reduced inflammation in wound and tendon models. One scoping review mapped evidence as heavily weighted toward in vitro and animal designs, with sparse direct musculoskeletal human data.\n\n## What scientists say\n\nResearchers note that thymosin beta-4 supports actin sequestration and cell motility in repair contexts, but emphasize the absence of randomized controlled trials in nerve compression or tendon sheath conditions like carpal tunnel. A 2026 review concluded the literature supports interest in repair pathways yet remains largely preclinical for musculoskeletal applications.\n\n## What people say on Reddit\n\nAnecdotal reports appear in r/carpaltunnel and r/Peptides. Users describe combining TB-500 with BPC-157 and reporting reduced numbness, less pain with repetitive use, and improved thumb pad comfort within weeks. One user stated relief was \"almost immediate\" after injection near the pain site. Another noted help with tendon issues in hands and arms after a fall. Several threads mention post-surgery use or attempts to avoid surgery. These remain individual experiences without controlled verification.\n\n## What people say on X\n\nPublic posts on X echo similar themes of users trying TB-500 blends for wrist and nerve issues, often alongside other peptides, with reports of faster perceived recovery from repetitive strain. No large verified cohort data appears.\n\n## What we do not know\n\nNo human efficacy trials measure nerve conduction, symptom scores, or imaging changes after TB-500 in carpal tunnel patients. Long-term outcomes, optimal timing relative to compression severity, and whether effects differ from placebo are unknown. Direct comparisons to standard care such as splinting or corticosteroid injection do not exist.\n\n## Safety and limits\n\nPhase 1 safety data on recombinant thymosin beta-4 in healthy volunteers reported good tolerability at tested doses with no serious adverse events noted. Broader human safety data for the TB-500 fragment in carpal tunnel contexts is absent. Regulatory status limits approved medical use; any application remains experimental. Individual responses vary and monitoring by a qualified clinician is essential.\n\n(Word count approximately 1250)","claims":[{"id":"c1","text":"No completed human interventional trials test TB-500 for carpal tunnel syndrome.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the evidence gap for this specific condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"A 2026 scoping review found evidence for thymosin beta-4 and TB-500 heavily preclinical with limited human musculoskeletal data.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s1"],"source_status":"sourced","why_material":"Grades the overall literature base.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Reddit users report subjective pain and numbness reduction with TB-500 plus BPC-157 in carpal tunnel threads.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Documents real-world user reports separately from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Thymosin beta-4 pathways are studied for promoting cell migration and actin regulation in tissue repair.","section":"Why TB-500 might help you","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Links the peptide's researched actions to the condition's repair layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://www.mdpi.com/2076-3417/16/12/6202","title":"Thymosin Beta-4 and TB-500 in Tissue Healing: A Scoping Review","quote":"The evidence base was weighted toward mixed and in vitro designs... Human evidence directly relevant to musculoskeletal applications was limited, and direct TB-500 evidence was minimal.","link_status":"http_403","quote_status":"unverified"},{"id":"s2","type":"reddit","url":"https://www.reddit.com/r/carpaltunnel/comments/1j2tdik/has_anyone_tried_peptide_treatment_to_help_with/","title":"Has anyone tried peptide treatment to help with Carpal tunnel pain?","quote":"bpc157/ tb500 relieved the pain almost immediately.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"reddit","url":"https://www.reddit.com/r/carpaltunnel/comments/1qsstn0/peptides/","title":"Peptides?","quote":"My mom used it and claimed it helped completely gone. Specifically bpc-157 and tb-500. I'm currently taking it for my thenar thumb pad pain and it has helped.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":13819,"tokens_out":2533,"cost":0.02360625,"prev_hash":"genesis","hash":"276265cc0a25c683d14a6606b7f9a7d39b46aa7f4aebb4688bf282f653428012"}],"provenance":[{"ts":"2026-06-29T23:41:59.973Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: TB 500 for Carpal Tunnel\nSlug: tb-500-carpal-tunnel\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Carpal tunnel syndrome\",\"condition_key\":\"carpal-tunnel\",\"primary_peptide\":\"tb-500\",\"peptides_in_scope\":[{\"id\":\"tb-500\",\"name\":\"TB-500\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Carpal tunnel syndrome\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tb-500\",\"name\":\"TB-500\",\"section_title\":\"Why TB-500 might help you\",\"layer\":\"inflammation clearance / repair-cell migration\",\"steps\":[\"You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\",\"**What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\",\"**What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\",\"**Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — ce","response":"{\n  \"slug\": \"tb-500-carpal-tunnel\",\n  \"title\": \"TB-500 for Carpal Tunnel Syndrome: What the Evidence Shows\",\n  \"body\": \"## What's breaking down if you have Carpal tunnel syndrome\\n\\nCarpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel in the wrist. The flexor retinaculum ligament thickens or swells, pressure builds on the nerve and surrounding tendons. This leads to inflammation that does not clear quickly, restricted blood flow, and disrupted nerve signaling. Over time, the protective myelin around the nerve can degrade, and tendon gliding becomes impaired. Repair cells often fail to reach the compressed area efficiently because of poor migration through inflamed or scarred tissue. Actin and cytoskeleton organization in cells around the site can become disorganized, slowing structural rebuilding.\\n\\nThe core issue is a mismatch: breakdown and compression outpace the body's ability to clear inflammation and send repair cells where they are needed most.\\n\\n## Why TB-500 might help you\\n\\n1. You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\\n\\nIf your carpal tunnel involves persistent swelling around the nerve and tendons plus slow tissue remodeling, the pathways linked to TB-500 address cell movement and actin regulation that preclinical work associates with better repair-cell delivery to injury sites.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target othe","tokens_in":13819,"tokens_out":2533,"cost":0,"prev":"genesis","hash":"824d85410593675b856cd8d18ac0d06d3f750074d7e1cfb7b57d6036e336bc06"},{"ts":"2026-07-17T02:42:12.918Z","model":"owner","action":"voxel_divide","prompt":"","input":"tb-500-carpal-tunnel","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"824d85410593675b856cd8d18ac0d06d3f750074d7e1cfb7b57d6036e336bc06","hash":"d7947fe9ff80c0b625c70369518a4beb72782880078c88b4446f442f90b2ca31"}],"energy":{"passes":2,"tokens_in":13819,"tokens_out":2533,"tokens_total":16352,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"d7947fe9ff80c0b625c70369518a4beb72782880078c88b4446f442f90b2ca31"},"posted_at":"2026-06-29T21:33:26.422Z","created_at":"2026-06-29T21:33:26.422Z","updated_at":"2026-07-17T02:42:12.918Z","machine":{"shape":"article.machine/v1","slug":"tb-500-carpal-tunnel","kind":"article","read":{"human":"https://miscsubjects.com/a/tb-500-carpal-tunnel","json":"https://miscsubjects.com/api/articles/tb-500-carpal-tunnel","bundle":"https://miscsubjects.com/api/articles/tb-500-carpal-tunnel/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/tb-500-carpal-tunnel/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=tb-500-carpal-tunnel","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-carpal-tunnel\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-carpal-tunnel\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/tb-500-carpal-tunnel/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"tb-500-carpal-tunnel\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/tb-500-carpal-tunnel | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/tb-500-carpal-tunnel","json":"/api/articles/tb-500-carpal-tunnel","markdown":"/api/articles/tb-500-carpal-tunnel/bundle?format=markdown","skill":"/api/articles/tb-500-carpal-tunnel/skill","topology":"/api/articles/tb-500-carpal-tunnel/topology","versions":"/api/articles/tb-500-carpal-tunnel/revisions","invocations":"/api/articles/tb-500-carpal-tunnel/invocations"},"editorial_review":null,"editorial_audit":{"slug":"tb-500-carpal-tunnel","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"95d94209014b85dfdf3c7a661e39234666ac5347ec8ee185ce55f3bdd96762cd","object":{"object_type":"article-object","identity":{"id":"article:tb-500-carpal-tunnel","slug":"tb-500-carpal-tunnel","title":"TB-500 for Carpal Tunnel Syndrome: What the Evidence Shows"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/tb-500-carpal-tunnel","role":"explain","audience":"human"},"skill":{"route":"/api/articles/tb-500-carpal-tunnel/skill","role":"direct behavior","audience":"model","content":"---\nname: tb-500-carpal-tunnel\ndescription: Apply the TB-500 for Carpal Tunnel Syndrome: What the Evidence Shows article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# TB-500 for Carpal Tunnel Syndrome: What the Evidence Shows\n\nThis Skill is the behavioral expression of [the canonical article](/a/tb-500-carpal-tunnel). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/tb-500-carpal-tunnel.\n- Read claims and relationships at /api/articles/tb-500-carpal-tunnel/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down if you have Carpal tunnel syndrome Carpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel in the wrist. The flexor retinaculum ligament thickens or swells, pressure\n\n## Representations\n\n- Human: /a/tb-500-carpal-tunnel\n- JSON: /api/articles/tb-500-carpal-tunnel\n- Relationships: /api/articles/tb-500-carpal-tunnel/topology\n- History: /api/articles/tb-500-carpal-tunnel/revisions\n"},"json":{"route":"/api/articles/tb-500-carpal-tunnel","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/tb-500-carpal-tunnel/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","tb","500","carpal","tunnel"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/tb-500-carpal-tunnel/invocations?status=success","failure_events":"/api/articles/tb-500-carpal-tunnel/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"tb-500-carpal-tunnel","title":"TB-500 for Carpal Tunnel Syndrome: What the Evidence Shows","body":"## What's breaking down if you have Carpal tunnel syndrome\n\nCarpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel in the wrist. The flexor retinaculum ligament thickens or swells, pressure builds on the nerve and surrounding tendons. This leads to inflammation that does not clear quickly, restricted blood flow, and disrupted nerve signaling. Over time, the protective myelin around the nerve can degrade, and tendon gliding becomes impaired. Repair cells often fail to reach the compressed area efficiently because of poor migration through inflamed or scarred tissue. Actin and cytoskeleton organization in cells around the site can become disorganized, slowing structural rebuilding.\n\nThe core issue is a mismatch: breakdown and compression outpace the body's ability to clear inflammation and send repair cells where they are needed most.\n\n## Why TB-500 might help you\n\n1. You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\nIf your carpal tunnel involves persistent swelling around the nerve and tendons plus slow tissue remodeling, the pathways linked to TB-500 address cell movement and actin regulation that preclinical work associates with better repair-cell delivery to injury sites.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **TB-500** → inflammation clearance / repair-cell migration\n\n## What the evidence actually shows\n\nNo completed human interventional trials exist that test TB-500 specifically for carpal tunnel syndrome (scoping review of 80 studies, 2026). Human data on thymosin beta-4 (the parent peptide) is limited to safety studies in healthy volunteers and small trials in ocular or cardiac settings. Preclinical work in animals shows thymosin beta-4 promotes cell migration, angiogenesis, and reduced inflammation in wound and tendon models. One scoping review mapped evidence as heavily weighted toward in vitro and animal designs, with sparse direct musculoskeletal human data.\n\n## What scientists say\n\nResearchers note that thymosin beta-4 supports actin sequestration and cell motility in repair contexts, but emphasize the absence of randomized controlled trials in nerve compression or tendon sheath conditions like carpal tunnel. A 2026 review concluded the literature supports interest in repair pathways yet remains largely preclinical for musculoskeletal applications.\n\n## What people say on Reddit\n\nAnecdotal reports appear in r/carpaltunnel and r/Peptides. Users describe combining TB-500 with BPC-157 and reporting reduced numbness, less pain with repetitive use, and improved thumb pad comfort within weeks. One user stated relief was \"almost immediate\" after injection near the pain site. Another noted help with tendon issues in hands and arms after a fall. Several threads mention post-surgery use or attempts to avoid surgery. These remain individual experiences without controlled verification.\n\n## What people say on X\n\nPublic posts on X echo similar themes of users trying TB-500 blends for wrist and nerve issues, often alongside other peptides, with reports of faster perceived recovery from repetitive strain. No large verified cohort data appears.\n\n## What we do not know\n\nNo human efficacy trials measure nerve conduction, symptom scores, or imaging changes after TB-500 in carpal tunnel patients. Long-term outcomes, optimal timing relative to compression severity, and whether effects differ from placebo are unknown. Direct comparisons to standard care such as splinting or corticosteroid injection do not exist.\n\n## Safety and limits\n\nPhase 1 safety data on recombinant thymosin beta-4 in healthy volunteers reported good tolerability at tested doses with no serious adverse events noted. Broader human safety data for the TB-500 fragment in carpal tunnel contexts is absent. Regulatory status limits approved medical use; any application remains experimental. Individual responses vary and monitoring by a qualified clinician is essential.\n\n(Word count approximately 1250)","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/tb-500-carpal-tunnel/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No completed human interventional trials test TB-500 for carpal tunnel syndrome.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the evidence gap for this specific condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"A 2026 scoping review found evidence for thymosin beta-4 and TB-500 heavily preclinical with limited human musculoskeletal data.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s1"],"source_status":"sourced","why_material":"Grades the overall literature base.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Reddit users report subjective pain and numbness reduction with TB-500 plus BPC-157 in carpal tunnel threads.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Documents real-world user reports separately from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Thymosin beta-4 pathways are studied for promoting cell migration and actin regulation in tissue repair.","section":"Why TB-500 might help you","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Links the peptide's researched actions to the condition's repair layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://www.mdpi.com/2076-3417/16/12/6202","title":"Thymosin Beta-4 and TB-500 in Tissue Healing: A Scoping Review","quote":"The evidence base was weighted toward mixed and in vitro designs... Human evidence directly relevant to musculoskeletal applications was limited, and direct TB-500 evidence was minimal.","summary":"2026 scoping review mapping TB-500/Tβ4 evidence; no human interventional musculoskeletal trials identified for administered peptide.","claim_ids":["c1","c2","c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:41:59.529Z","link_status":"http_403","quote_status":"unverified","prev":"genesis","hash":"03fe79c420da85b83c16a0aa6188d80b8d03b59f13257d64c6812c7b0617772c"},{"id":"s2","type":"reddit","url":"https://www.reddit.com/r/carpaltunnel/comments/1j2tdik/has_anyone_tried_peptide_treatment_to_help_with/","title":"Has anyone tried peptide treatment to help with Carpal tunnel pain?","quote":"bpc157/ tb500 relieved the pain almost immediately.","summary":"User report of rapid subjective relief from BPC-157/TB-500 blend in carpal tunnel.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:41:59.529Z","link_status":"ok","quote_status":"unverified","prev":"03fe79c420da85b83c16a0aa6188d80b8d03b59f13257d64c6812c7b0617772c","hash":"86deb4d5e858ce4268c8ff98c9567ba00c0a0342ad8edfc0f732ad4ce575bf3f"},{"id":"s3","type":"reddit","url":"https://www.reddit.com/r/carpaltunnel/comments/1qsstn0/peptides/","title":"Peptides?","quote":"My mom used it and claimed it helped completely gone. Specifically bpc-157 and tb-500. I'm currently taking it for my thenar thumb pad pain and it has helped.","summary":"Additional anecdotal reports of symptom improvement with the blend.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:41:59.529Z","link_status":"ok","quote_status":"unverified","prev":"86deb4d5e858ce4268c8ff98c9567ba00c0a0342ad8edfc0f732ad4ce575bf3f","hash":"f3a039771d5f33568e7b0b40e2973c794fa6e6ab2a73ac66ceff166526d1e8fd"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:41:59.973Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"TB-500 for Carpal Tunnel Syndrome: What the Evidence Shows","register":"source_ledger","body":"## What's breaking down if you have Carpal tunnel syndrome\n\nCarpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel in the wrist. The flexor retinaculum ligament thickens or swells, pressure builds on the nerve and surrounding tendons. This leads to inflammation that does not clear quickly, restricted blood flow, and disrupted nerve signaling. Over time, the protective myelin around the nerve can degrade, and tendon gliding becomes impaired. Repair cells often fail to reach the compressed area efficiently because of poor migration through inflamed or scarred tissue. Actin and cytoskeleton organization in cells around the site can become disorganized, slowing structural rebuilding.\n\nThe core issue is a mismatch: breakdown and compression outpace the body's ability to clear inflammation and send repair cells where they are needed most.\n\n## Why TB-500 might help you\n\n1. You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\nIf your carpal tunnel involves persistent swelling around the nerve and tendons plus slow tissue remodeling, the pathways linked to TB-500 address cell movement and actin regulation that preclinical work associates with better repair-cell delivery to injury sites.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **TB-500** → inflammation clearance / repair-cell migration\n\n## What the evidence actually shows\n\nNo completed human interventional trials exist that test TB-500 specifically for carpal tunnel syndrome (scoping review of 80 studies, 2026). Human data on thymosin beta-4 (the parent peptide) is limited to safety studies in healthy volunteers and small trials in ocular or cardiac settings. Preclinical work in animals shows thymosin beta-4 promotes cell migration, angiogenesis, and reduced inflammation in wound and tendon models. One scoping review mapped evidence as heavily weighted toward in vitro and animal designs, with sparse direct musculoskeletal human data.\n\n## What scientists say\n\nResearchers note that thymosin beta-4 supports actin sequestration and cell motility in repair contexts, but emphasize the absence of randomized controlled trials in nerve compression or tendon sheath conditions like carpal tunnel. A 2026 review concluded the literature supports interest in repair pathways yet remains largely preclinical for musculoskeletal applications.\n\n## What people say on Reddit\n\nAnecdotal reports appear in r/carpaltunnel and r/Peptides. Users describe combining TB-500 with BPC-157 and reporting reduced numbness, less pain with repetitive use, and improved thumb pad comfort within weeks. One user stated relief was \"almost immediate\" after injection near the pain site. Another noted help with tendon issues in hands and arms after a fall. Several threads mention post-surgery use or attempts to avoid surgery. These remain individual experiences without controlled verification.\n\n## What people say on X\n\nPublic posts on X echo similar themes of users trying TB-500 blends for wrist and nerve issues, often alongside other peptides, with reports of faster perceived recovery from repetitive strain. No large verified cohort data appears.\n\n## What we do not know\n\nNo human efficacy trials measure nerve conduction, symptom scores, or imaging changes after TB-500 in carpal tunnel patients. Long-term outcomes, optimal timing relative to compression severity, and whether effects differ from placebo are unknown. Direct comparisons to standard care such as splinting or corticosteroid injection do not exist.\n\n## Safety and limits\n\nPhase 1 safety data on recombinant thymosin beta-4 in healthy volunteers reported good tolerability at tested doses with no serious adverse events noted. Broader human safety data for the TB-500 fragment in carpal tunnel contexts is absent. Regulatory status limits approved medical use; any application remains experimental. Individual responses vary and monitoring by a qualified clinician is essential.\n\n(Word count approximately 1250)","claims":[{"id":"c1","text":"No completed human interventional trials test TB-500 for carpal tunnel syndrome.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the evidence gap for this specific condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"A 2026 scoping review found evidence for thymosin beta-4 and TB-500 heavily preclinical with limited human musculoskeletal data.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s1"],"source_status":"sourced","why_material":"Grades the overall literature base.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Reddit users report subjective pain and numbness reduction with TB-500 plus BPC-157 in carpal tunnel threads.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Documents real-world user reports separately from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Thymosin beta-4 pathways are studied for promoting cell migration and actin regulation in tissue repair.","section":"Why TB-500 might help you","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Links the peptide's researched actions to the condition's repair layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:41:59.569Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://www.mdpi.com/2076-3417/16/12/6202","title":"Thymosin Beta-4 and TB-500 in Tissue Healing: A Scoping Review","quote":"The evidence base was weighted toward mixed and in vitro designs... Human evidence directly relevant to musculoskeletal applications was limited, and direct TB-500 evidence was minimal.","link_status":"http_403","quote_status":"unverified"},{"id":"s2","type":"reddit","url":"https://www.reddit.com/r/carpaltunnel/comments/1j2tdik/has_anyone_tried_peptide_treatment_to_help_with/","title":"Has anyone tried peptide treatment to help with Carpal tunnel pain?","quote":"bpc157/ tb500 relieved the pain almost immediately.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"reddit","url":"https://www.reddit.com/r/carpaltunnel/comments/1qsstn0/peptides/","title":"Peptides?","quote":"My mom used it and claimed it helped completely gone. Specifically bpc-157 and tb-500. I'm currently taking it for my thenar thumb pad pain and it has helped.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":13819,"tokens_out":2533,"cost":0.02360625,"prev_hash":"genesis","hash":"276265cc0a25c683d14a6606b7f9a7d39b46aa7f4aebb4688bf282f653428012"}],"provenance":[{"ts":"2026-06-29T23:41:59.973Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: TB 500 for Carpal Tunnel\nSlug: tb-500-carpal-tunnel\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Carpal tunnel syndrome\",\"condition_key\":\"carpal-tunnel\",\"primary_peptide\":\"tb-500\",\"peptides_in_scope\":[{\"id\":\"tb-500\",\"name\":\"TB-500\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Carpal tunnel syndrome\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tb-500\",\"name\":\"TB-500\",\"section_title\":\"Why TB-500 might help you\",\"layer\":\"inflammation clearance / repair-cell migration\",\"steps\":[\"You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\",\"**What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\",\"**What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\",\"**Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — ce","response":"{\n  \"slug\": \"tb-500-carpal-tunnel\",\n  \"title\": \"TB-500 for Carpal Tunnel Syndrome: What the Evidence Shows\",\n  \"body\": \"## What's breaking down if you have Carpal tunnel syndrome\\n\\nCarpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel in the wrist. The flexor retinaculum ligament thickens or swells, pressure builds on the nerve and surrounding tendons. This leads to inflammation that does not clear quickly, restricted blood flow, and disrupted nerve signaling. Over time, the protective myelin around the nerve can degrade, and tendon gliding becomes impaired. Repair cells often fail to reach the compressed area efficiently because of poor migration through inflamed or scarred tissue. Actin and cytoskeleton organization in cells around the site can become disorganized, slowing structural rebuilding.\\n\\nThe core issue is a mismatch: breakdown and compression outpace the body's ability to clear inflammation and send repair cells where they are needed most.\\n\\n## Why TB-500 might help you\\n\\n1. You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\\n\\nIf your carpal tunnel involves persistent swelling around the nerve and tendons plus slow tissue remodeling, the pathways linked to TB-500 address cell movement and actin regulation that preclinical work associates with better repair-cell delivery to injury sites.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target othe","tokens_in":13819,"tokens_out":2533,"cost":0,"prev":"genesis","hash":"824d85410593675b856cd8d18ac0d06d3f750074d7e1cfb7b57d6036e336bc06"},{"ts":"2026-07-17T02:42:12.918Z","model":"owner","action":"voxel_divide","prompt":"","input":"tb-500-carpal-tunnel","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"824d85410593675b856cd8d18ac0d06d3f750074d7e1cfb7b57d6036e336bc06","hash":"d7947fe9ff80c0b625c70369518a4beb72782880078c88b4446f442f90b2ca31"}],"energy":{"passes":2,"tokens_in":13819,"tokens_out":2533,"tokens_total":16352,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"d7947fe9ff80c0b625c70369518a4beb72782880078c88b4446f442f90b2ca31"},"posted_at":"2026-06-29T21:33:26.422Z","created_at":"2026-06-29T21:33:26.422Z","updated_at":"2026-07-17T02:42:12.918Z","machine":{"shape":"article.machine/v1","slug":"tb-500-carpal-tunnel","kind":"article","read":{"human":"https://miscsubjects.com/a/tb-500-carpal-tunnel","json":"https://miscsubjects.com/api/articles/tb-500-carpal-tunnel","bundle":"https://miscsubjects.com/api/articles/tb-500-carpal-tunnel/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/tb-500-carpal-tunnel/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=tb-500-carpal-tunnel","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-carpal-tunnel\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-carpal-tunnel\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/tb-500-carpal-tunnel/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"tb-500-carpal-tunnel\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/tb-500-carpal-tunnel | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/tb-500-carpal-tunnel","json":"/api/articles/tb-500-carpal-tunnel","markdown":"/api/articles/tb-500-carpal-tunnel/bundle?format=markdown","skill":"/api/articles/tb-500-carpal-tunnel/skill","topology":"/api/articles/tb-500-carpal-tunnel/topology","versions":"/api/articles/tb-500-carpal-tunnel/revisions","invocations":"/api/articles/tb-500-carpal-tunnel/invocations"},"editorial_review":null,"editorial_audit":{"slug":"tb-500-carpal-tunnel","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"95d94209014b85dfdf3c7a661e39234666ac5347ec8ee185ce55f3bdd96762cd"}}}